| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/11/2013 | CN102816732B MDCK cell line suitable for full suspended serum-free culture and its application in culturing of influenza virus and production of influenza virus vaccines |
| 12/11/2013 | CN102813922B Compound oil adjuvant as well as preparation method and application thereof |
| 12/11/2013 | CN102813915B Drug-induced subcellular structure vaccine and preparation method thereof |
| 12/11/2013 | CN102614507B Type O foot-and-mouth disease virus molecular marker vaccine and preparation method thereof |
| 12/11/2013 | CN102526720B Preparation method of influenza virus vaccine |
| 12/11/2013 | CN102286391B Mink hemorrhagic pneumonia divalent inactivated vaccine and preparation method threof |
| 12/11/2013 | CN102180974B Tubercle bacillus fusion protein and preparation method and application thereof |
| 12/11/2013 | CN102056591B Liposome medicament and preparation method and use thereof |
| 12/11/2013 | CN101790384B The use of monomycolyl glycerol (mmg) as an adjuvant |
| 12/11/2013 | CN101616688B Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 12/10/2013 | US8604179 Nucleic acid comprising chimeric gene derived from hepatitis C virus |
| 12/10/2013 | US8604178 Compositions and methods of enhancing immune responses |
| 12/10/2013 | US8604174 High affinity fully human monoclonal antibodies to interleukin-8 |
| 12/10/2013 | US8604171 High affinity, anti-human IgE antibodies |
| 12/10/2013 | US8604169 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| 12/10/2013 | US8603987 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 12/10/2013 | US8603796 Method for producing storage stable viruses and immunogenic compositions thereof |
| 12/10/2013 | US8603794 Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
| 12/10/2013 | US8603793 Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
| 12/10/2013 | US8603778 Anti-TNF antibodies, compositions, methods and uses |
| 12/10/2013 | US8603491 cDNA construct of salmonidae alphavirus |
| 12/10/2013 | US8603490 Modified human immunodeficiency virus clade C envelope polypeptides obtained from a zambian isolate |
| 12/10/2013 | US8603487 Palmitoylated AB 1-15 in a liposome as a treatment for amyloid associated diseases |
| 12/10/2013 | US8603486 Protein A compositions and methods of use |
| 12/10/2013 | US8603485 Bystander immune suppression as a predictor for response to a vaccine |
| 12/10/2013 | US8603484 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 12/10/2013 | US8603483 Anti-integrin immunoconjugates, methods and uses |
| 12/10/2013 | US8603482 Compositions and methods for cancer immunotherapy |
| 12/10/2013 | US8603481 Therapeutic agents for solid tumors |
| 12/10/2013 | US8603480 Human cytomegalovirus neutralizing antibodies and use thereof |
| 12/10/2013 | US8603479 Class I anti-CEA antibodies and uses thereof |
| 12/10/2013 | US8603478 Anti-RON antibodies |
| 12/10/2013 | US8603477 Use of anti-CS1 antibodies for treatment of rare lymphomas |
| 12/10/2013 | US8603476 Humanized anti-human α9-integrin antibody |
| 12/10/2013 | US8603475 Methods and compositions for targeting polyubiquitin |
| 12/10/2013 | US8603474 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 12/10/2013 | US8603473 Modified binding molecules comprising connecting peptides |
| 12/10/2013 | US8603472 Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide |
| 12/10/2013 | US8603471 Methods and compositions for preventing the onset of type 1 diabetes |
| 12/10/2013 | US8603470 Use of IL-20 antagonists for treating liver diseases |
| 12/10/2013 | US8603469 Methods of treating cancer with human monoclonal antibodies against interleukin 8 |
| 12/10/2013 | US8603468 Neutralization of HCV |
| 12/10/2013 | US8603467 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof |
| 12/10/2013 | US8603466 Agonist antibodies against TSHR |
| 12/10/2013 | US8603465 Methods for treatment of polyposis |
| 12/10/2013 | US8603459 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 12/10/2013 | US8603458 Genetic adjuvants for immunotherapy |
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | US8602998 Use of relaxin to increase arterial compliance |
| 12/10/2013 | CA2658582C Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 12/10/2013 | CA2623531C Matrix metalloproteinase 11 vaccine |
| 12/10/2013 | CA2613732C Thermoreversible immuno-adjuvant emulsion |
| 12/10/2013 | CA2541535C Antibodies to nik, their preparation and use |
| 12/10/2013 | CA2502367C Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 12/10/2013 | CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 12/10/2013 | CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/10/2013 | CA2464700C Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 12/10/2013 | CA2453173C Mycobacterial antigens expressed during latency |
| 12/10/2013 | CA2451026C Mycobacterial antigens expressed under low oxygen tension |
| 12/10/2013 | CA2443617C Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 12/10/2013 | CA2415325C Preventing airway mucus production by administration of egf-r antagonists |
| 12/10/2013 | CA2385528C Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 12/10/2013 | CA2385032C G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2013 | CA2341349C Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| 12/05/2013 | WO2013181618A2 Methods to treat alzheimer's disease using apoe inhibitors |
| 12/05/2013 | WO2013181613A1 Mirna for the diagnosis and treatment of autoimmune and inflammatory disease |
| 12/05/2013 | WO2013181557A1 Targeting cancer cells and tissue using filamentous plant virus particles |
| 12/05/2013 | WO2013181543A1 High-affinity monoclonal antibodies to glypican-3 and use thereof |
| 12/05/2013 | WO2013181495A2 Compositions comprising an anti-pdgf aptamer and a vegf antagonist |
| 12/05/2013 | WO2013181486A1 Stabilized formulations containing anti-dll4 antibodies |
| 12/05/2013 | WO2013181452A1 Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists |
| 12/05/2013 | WO2013181270A1 Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof |
| 12/05/2013 | WO2013181087A2 Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy |
| 12/05/2013 | WO2013181086A1 Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections |
| 12/05/2013 | WO2013181016A2 Treatment for the rapid amelioration of clinical depression |
| 12/05/2013 | WO2013180967A1 Herpes simplex virus vaccine |
| 12/05/2013 | WO2013180834A2 Compositions and methods of inhibting masp-1 and/or masp-3 for the treatment of paroxysmal nocturnal hemoglobinuria |
| 12/05/2013 | WO2013180274A1 Chemotherapy selection method for stomach cancer patients |
| 12/05/2013 | WO2013180238A1 Therapeutic agent or prophylactic agent for dementia |
| 12/05/2013 | WO2013180201A1 Antigen-binding molecule for eliminating aggregated antigens |
| 12/05/2013 | WO2013180200A1 Target-tissue-specific antigen-binding molecule |
| 12/05/2013 | WO2013179302A1 Oral anti-inflammatory formulation comprising potentised cytokine |
| 12/05/2013 | WO2013179262A1 Immunogenic compounds comprising hiv gp41 peptide coupled to crm197 carrier protein |
| 12/05/2013 | WO2013179044A2 Cladosporium peptides |
| 12/05/2013 | WO2013179043A1 Alternaria peptides |
| 12/05/2013 | WO2013178947A1 Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition |
| 12/05/2013 | WO2013178706A1 Novel il-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of il-3 |
| 12/05/2013 | WO2013178236A1 Carbohydrate-glycolipid conjugate vaccines |
| 12/05/2013 | WO2013178079A1 Tumor vaccine and preparation method thereof |
| 12/05/2013 | WO2013177922A1 Polypeptide for treating alzheimer's disease and genetic vaccine |
| 12/05/2013 | WO2013177699A1 Inflammation-enabling polypeptides and uses thereof |
| 12/05/2013 | WO2013177605A1 Destructured and modified virus immunogens |
| 12/05/2013 | WO2013154458A3 Monomolecular chimeric t-cell receptor to a carcinoembryonic antigen |
| 12/05/2013 | WO2013152351A3 Fusion polypeptides and methods of use thereof |
| 12/05/2013 | WO2013123114A3 Anti-vla1 (cd49a) antibody pharmaceutical compositions |
| 12/05/2013 | WO2013104901A3 Novel therapies |
| 12/05/2013 | WO2013064700A3 Chimeric human-camel antigens and their use |
| 12/05/2013 | US20130323635 Method of manufacturing resin particles, apparatus for manufacturing resin particles, and image forming apparatus |
| 12/05/2013 | US20130323301 Enhanced cancer treatment and monitoring using recombinant vectors |
| 12/05/2013 | US20130323299 Method of inducing neutralizing antibodies to human immunodeficiency virus |